Purdue compounds shown to stimulate powerful antitumor immune responses
Researchers at Purdue University have developed a small-molecule compound that could open a new route toward cancer immunotherapy by targeting ...
Tag: targeted cancer therapy
Stanford study shows molecular glue converts cancer driver into built-in kill switch
A two-headed experimental drug has eradicated aggressive human lymphoma tumors in mice by turning one of cancer’s most important growth-driving ...
Targeting Purine Metabolism Emerges as a Next-Generation Cancer Treatment Strategy
Cancer cells do not merely consume more nutrients than healthy cells; they redesign the systems that process those nutrients to ...
Locking therapeutic strategy could make cancer treatment more precise
Although modern cancer treatments can eliminate malignant cells with remarkable efficiency, their lack of perfect selectivity often exposes healthy tissues ...
New strategy shows promise against cancer drug resistance
A protein that helps cancer cells control oxidative stress may explain why some blood cancers eventually stop responding to BTK ...
Targeted therapy combinations may overcome treatment resistance in advanced prostate cancer
UCLA researchers have identified a way to make antibody-drug conjugates more powerful against metastatic castration-resistant prostate cancer, an advanced form ...
LIG1 Loss Reveals Targetable Weakness Against Chemotherapy-Resistant Triple-Negative Breast Cancer
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
Oncogene Inactivation–Triggered Senescence Enables Tumor Relapse
A new study in Nature Communications reveals how cancer cells can use the body’s own defenses against them. The work, ...
Engineered Zwitterion Nanodelivery Enables Precise Brain Metastases Targeting
A groundbreaking study published in Nature Communications unveils a novel approach to treating brain metastases with unprecedented precision and efficacy. ...
Olaparib Benefits HR-Deficient TNBC and Platinum-Sensitive Ovarian Cancers
In a groundbreaking phase 2 clinical trial, researchers have demonstrated the efficacy of olaparib, a PARP inhibitor, in treating metastatic ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!